
BioNTech lowers full-year revenue outlook on COVID-19 seasonality, inventory write-downs
(Reuters) – German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing C...
4th November, 2024

(Reuters) – German drugmaker BioNTech on Monday lowered its guidance for full-year revenue, citing C...
4th November, 2024

Majid Muhammad, Chief Information Officer, Resimac and Theo Albers, Regional Head for ANZ, Infosys F...
4th November, 2024

(Reuters) – Italy’s Prysmian and Britain’s TechnipFMC signed an agreement to strengthen the developm...
4th November, 2024

SHANGHAI (Reuters) – Chinese electric vehicle maker Nio is planning to launch its first hybrid model...
4th November, 2024

By Jeffrey Dastin (Reuters) – Intel’s upbeat revenue projections on Thursday masked a sore point for...
1st November, 2024

LONDON (Reuters) – Prince William jets to South Africa next week for the start of a four day trip wh...
1st November, 2024

By Kenrick Cai (Reuters) – Alphabet’s Google on Thursday announced a set of features that incorporat...
1st November, 2024

By Max A. Cherney and Arsheeya Bajwa (Reuters) -Intel expressed optimism on Thursday about the futur...
1st November, 2024

By Stephen Nellis, Akash Sriram (Reuters) -Apple’s AI-enhanced iPhone made a strong start, pushing q...
1st November, 2024

By Mike Stone HUNTSVILLE, Alabama (Reuters) – Investments by L3Harris Technologies into its Aerojet...
31st October, 2024

By Foo Yun Chee BRUSSELS (Reuters) -U.S. chipmaker Nvidia will have to seek EU antitrust clearance f...
31st October, 2024

By Zaheer Kachwala (Reuters) -Videogame platform Roblox raised its forecast for full-year 2024 booki...
31st October, 2024